本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Evolent Health Inc

4.19
+0.02000.48%
盤後4.190.00000.00%19:30 EDT
成交量:169.72萬
成交額:706.00萬
市值:4.74億
市盈率:-0.92
高:4.23
開:4.19
低:4.10
收:4.17
52周最高:9.63
52周最低:2.10
股本:1.13億
流通股本:9,414.80萬
量比:0.90
換手率:1.80%
股息:- -
股息率:- -
每股收益(TTM):-4.5419
每股收益(LYR):-5.0732
淨資產收益率:-66.97%
總資產收益率:-0.78%
市淨率:1.24
市盈率(LYR):-0.83

資料載入中...

2024/08/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/08

重要事件披露

Form 8-K - Current report
2024/08/07

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/06/17

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/06/11

重要事件披露

Form 8-K - Current report
2024/06/04

重要事件披露

Form 8-K - Current report
2024/05/10

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/04/09

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/23

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/22

重要事件披露

Form 8-K - Current report
2024/02/15

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/08

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/18

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/08

重要事件披露

Form 8-K - Current report